Aerosolized iloprost as a bridge to lung transplantation in a patient with cystic fibrosis and pulmonary hypertension.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 15337084.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We describe a patient with cystic fibrosis, end-stage lung disease, and secondary pulmonary hypertension in whom aerosolized iloprost was effective in lowering pulmonary artery pressure and improving functional status, thus proving successful as a bridge to lung transplantation. Inhaled iloprost may be an efficient and selective approach to treat pulmonary hypertension related to end-stage obstructive pulmonary disease.
Medical subject headings
- Cystic Fibrosis
- Hypertension, Pulmonary
- Iloprost
- Lung Transplantation
- Premedication
- Respiratory Insufficiency
- Vasodilator Agents